← Back to all trials
Active Not Recruiting
NCT03995121
SV2 PET Imaging With [11C]APP311
Conditions: Schizophrenia and Other Psychotic Disorders, Cannabis Use Disorder, Healthy
Sex: All
Ages: 18 Years – 85 Years
Healthy volunteers: Yes
Enrollment: 250
Sponsor: Yale University
Location: Conneticut Mental Health Center New Haven Connecticut
Summary
The aim of this study is to evaluate a new SV2A tracer, \[11C\]APP311, in healthy aging and neuropsychiatric disorders including psychotic disorders and cannabis use disorders.
Eligibility Criteria
Inclusion Criteria:
* Willing and able to give voluntary written informed consent
* Male and Female subjects, age 18 to 65 years, inclusive
Exclusion Criteria:
* MRI metal exclusions and claustrophobia.
* Education completed is less than 12 years
Source: ClinicalTrials.gov (NCT03995121). StuddyBuddy aggregates publicly available trial information.
